Mizuho Securities analyst Anthony Petrone maintains $Intuitive Surgical (ISRG.US)$ with a hold rating, and adjusts the target price from $500 to $550.
According to TipRanks data, the analyst has a success rate of 51.4% and a total average return of 8.4% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's Q3 earnings surpassed expectations, signaling a robust quarter propelled by significant placements of the Da Vinci 5 system, a strong increase in procedure volumes, and sustained margin discipline. Additionally, the company has elevated its FY24 procedure volume growth forecast to a range of 16%-17%, taking into account the potential for continued challenges in bariatric procedures and the impact of ongoing physician strikes in Korea, as well as the current state of affairs in China.
The sentiment that the market may be anticipating a substantial revenue outperformance for FY25 was expressed, particularly after the company's earnings report led to an approximate 3% increase in FY25 EPS estimates.
Intuitive Surgical exhibited 'strong' results for Q3, surpassing expectations in the two most crucial metrics - DV5 placements and procedure growth. Following the U.S. approval of the da Vinci 5, the company has quickly gained significant growth momentum. The early adoption of DV5 is progressing faster than the launch of the fourth-generation system, with promising indications of further growth acceleration as we approach 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
瑞穗證券分析師Anthony Petrone維持$直覺外科公司 (ISRG.US)$持有評級，並將目標價從500美元上調至550美元。
根據TipRanks數據顯示，該分析師近一年總勝率為51.4%，總平均回報率為8.4%。
此外，綜合報道，$直覺外科公司 (ISRG.US)$近期主要分析師觀點如下：
直覺外科公司第三季度收益超出預期，表明受到達芬奇5系統大量部署、手術量大幅增加和持續的保持利潤率的推動，季度強勁。此外，該公司已將其FY24手術量增長預測提升至16%-17%的區間，考慮到BEN手術持續面臨的挑戰以及韓國持續的醫師罷工影響，以及中國當前局勢。
市場可能在預期FY25年營業收入優於預期，尤其是在該公司業績導致FY25每股收益預期大約增加3%後。
直覺外科公司第三季度展現出「強勁」的業績，超出了兩個最關鍵的指標——DV5部署和手術量增長的預期。在獲得達芬奇5的美國批准後，該公司迅速獲得了顯著增長動力。DV5的早期採用速度比第四代系統的推出速度快，有跡象表明隨着我們接近2025年，進一步增長加速發展。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
